| P50 | author | Kimberly K Leslie | Q56915077 |
| P2093 | author name string | Marilee Morgan | |
| | Gavin Pickett | |
| | Suzy Davies | |
| | Lina Albitar | |
| P2860 | cites work | Analysis of the retinoblastoma gene in human endometrial carcinoma | Q41201953 |
| | Regulation of cyclin E protein levels through E2F-mediated inhibition of degradation | Q42820103 |
| | Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells. | Q45086128 |
| | Uterine papillary serous carcinoma evolves via a p53-driven pathway. | Q53449426 |
| | Cancer risk associated with germline DNA mismatch repair gene mutations | Q56813769 |
| | The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways | Q73459314 |
| | Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells. Only progesterone receptor B is induced by estrogen and associated with strong transcriptional activation | Q73786697 |
| | Clinicoprognostic significance of pRb1 pathway alterations in uterine endometrial adenocarcinoma | Q80841411 |
| | Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein | Q81241909 |
| | Endometrial cancer | Q81833884 |
| | Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers | Q28145813 |
| | Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 |
| | PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model | Q32069431 |
| | Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79 | Q33640362 |
| | Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature | Q33901618 |
| | p107 and p130: versatile proteins with interesting pockets | Q34174333 |
| | Two pathogenetic types of endometrial carcinoma | Q34713298 |
| | The Ishikawa Cells from Birth to the Present | Q35110565 |
| | Focus on endometrial and cervical cancer | Q35802630 |
| | Progesterone receptor isoform identification and subcellular localization in endometrial cancer | Q37371081 |
| | p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes | Q38478210 |
| | PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway | Q40736882 |
| | Endometrial cancer chemoprevention: implications of diverse pathways of carcinogenesis | Q41070219 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 52-64 | |
| P577 | publication date | 2007-05-08 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cells | |
| P478 | volume | 106 | |